SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

PLX READ THE FULL PLX RESEARCH REPORT Third Quarter 2024 Financial and Operational Review Protalix Biotherapeutics, Inc.

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

Common treatments, such as statins, are effective at lowering LDL cholesterol and have also shown to reduce inflammation, ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

"We are pleased to report that all eight cohorts of our phase I first-in-human study of PRX-115, our recombinant uricase candidate being developed for the treatment of uncontrolled gout, are now ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense and respond to danger. However, for people with risks for heart disease, ...

The symptoms include general fatigue and weakness, frequent urination, and Symptoms specific to underlying conditions, such as muscle weakness in Wilson's disease. “Chronic hyperuricemia can lead to ...

Certain strains of a bacterium found in the gut of some animals, Lactobacillus plantarum, are able to counter hyperuricemia, a condition caused by high levels of uric acid in the blood.